Aquestive Therapeutics, Inc. (AQST)

Latest Insider Confidence Score

2025Q4

46.9
Bearish

Company insider confidence (by quarter)

2018Q3 2025Q4

Largest shareholders

Insider Role (last 12 mo) Shares held Filed at
Schobel Alexander Mark Chief Innovation/Tech Officer 980,726 Oct 2, 2024
Barber Daniel CEO 923,430 Sep 29, 2025
Kraus Carl N Chief Medical Officer 282,475 Oct 17, 2025
Boyd Peter E. Officer 268,323 Dec 5, 2025
Cioffi Melina SVP, Regulatory Affairs 202,261 Dec 4, 2025

Recent buy/sell transactions

Exec date Filing date Insider Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Dec 4, 2025 Dec 5, 2025 Boyd Peter E. Chief People Officer Neutral 85.0 +20,000 7.45% ✗ -
Dec 2, 2025 Dec 4, 2025 Cioffi Melina SVP, Regulatory Affairs Sell 46.3 -2,083 -1.03% ✗ $12.4K
Nov 10, 2025 Nov 12, 2025 Davis Matthew W. Chief Development Officer Neutral 90.0 +50,000 100.00% ✗ -
Nov 12, 2025 Davis Matthew W. Chief Development Officer Neutral 52.5 - 0.00% ✗ -
Oct 15, 2025 Oct 17, 2025 Jung Cassie COO Sell 12.5 -67,575 -21.77% ✓ $473.7K
Oct 15, 2025 Oct 17, 2025 Kraus Carl N Chief Medical Officer Sell 32.5 -20,272 -6.70% ✓ $141.9K
Oct 15, 2025 Oct 17, 2025 Boyd Peter E. Officer Sell 37.5 -10,000 -3.59% ✓ $70K
Sep 26, 2025 Sep 29, 2025 Barber Daniel CEO Sell 26.3 -91,343 -9.00% ✓ $551.2K
Sep 26, 2025 Sep 29, 2025 Boyd Peter E. Officer Sell 37.5 -10,000 -3.47% ✓ $63K
Sep 19, 2025 Sep 22, 2025 Barber Daniel CEO Sell 58.8 -400 -0.04% ✓ $2.4K
Sep 4, 2025 Sep 8, 2025 Jung Cassie COO Sell 17.5 -62,180 -17.89% ✓ $310.9K
Sep 5, 2025 Sep 8, 2025 Boyd Peter E. Officer Sell 37.5 -15,000 -4.95% ✓ $79.5K
Aug 14, 2025 Aug 15, 2025 Korczynski Sherry Chief Commercial Officer Neutral 90.0 +25,000 15.94% ✗ -
Aug 9, 2025 Aug 12, 2025 Kraus Carl N Chief Medical Officer Sell 46.3 -10,819 -3.45% ✗ $42.2K
Jun 11, 2025 Jun 12, 2025 BROWN GREGORY B Director Neutral 52.5 - 0.00% ✗ -
Jun 11, 2025 Jun 12, 2025 Krop Julie Director Neutral 52.5 - 0.00% ✗ -
Jun 11, 2025 Jun 12, 2025 MORRIS TIMOTHY E Director Neutral 52.5 - 0.00% ✗ -
Jun 11, 2025 Jun 12, 2025 Jenkins Abigail L. Director Neutral 52.5 - 0.00% ✗ -
Jun 11, 2025 Jun 12, 2025 Cochran John Director Neutral 52.5 - 0.00% ✗ -
Jun 11, 2025 Jun 12, 2025 Taglietti Marco Director Neutral 52.5 - 0.00% ✗ -
Jun 9, 2025 Jun 10, 2025 Korczynski Sherry SVP Sales and Marketing Sell 47.5 -2,714 -1.70% ✗ $9.6K
May 15, 2025 May 15, 2025 Cioffi Melina SVP, Regulatory Affairs Neutral 90.0 +20,000 10.97% ✗ -
May 7, 2025 Cioffi Melina SVP Regulatory Affairs Neutral 52.5 - 0.00% ✗ -
Mar 7, 2025 Mar 11, 2025 Wargacki Stephen Chief Science Officer Sell 95.0 +82,138 31.42% ✗ $86.6K
Mar 7, 2025 Mar 11, 2025 Jung Cassie COO Sell 91.3 +62,460 26.57% ✗ $46.2K
Mar 7, 2025 Mar 11, 2025 TOTH A ERNEST JR CFO Sell 95.0 +91,071 36.68% ✗ $50.2K
Mar 7, 2025 Mar 11, 2025 Kraus Carl N Chief Medical Officer Sell 91.3 +61,885 24.59% ✗ $21.5K
Mar 7, 2025 Mar 11, 2025 Korczynski Sherry SVP Sales and Marketing Sell 91.3 +84,572 112.76% ✗ $14.4K
Mar 7, 2025 Mar 11, 2025 BRAENDER LORI J Chief Legal Officer Sell 95.0 +89,750 28.65% ✗ $53.7K
Mar 7, 2025 Mar 11, 2025 Boyd Peter E. Officer Sell 91.3 +65,695 27.65% ✗ $37.9K
Mar 7, 2025 Mar 11, 2025 Barber Daniel CEO Sell 95.0 +188,695 22.83% ✗ $220.8K
Dec 2, 2024 Dec 4, 2024 BRATTON DOUGLAS K 10% Owner Neutral 45.0 -40,000 -0.40% ✗ -
Nov 26, 2024 Nov 27, 2024 Jung Cassie COO Sell 52.5 -44 -0.02% ✗ $214.1
Mar 9, 2024 Oct 2, 2024 Schobel Alexander Mark Chief Innovation/Tech Officer Sell 48.8 -9,645 -0.97% ✗ $47.1K
Mar 9, 2024 Oct 2, 2024 Wargacki Stephen Chief Science Officer Sell 42.5 -19,505 -6.94% ✗ $95.2K
Mar 9, 2024 Oct 2, 2024 Barber Daniel CEO Sell 40.0 -56,824 -6.43% ✗ $277.3K
Mar 9, 2024 Oct 2, 2024 Jung Cassie SVP, Operations Sell 42.5 -14,120 -5.67% ✗ $68.9K
Aug 9, 2024 Aug 12, 2024 Kraus Carl N Chief Medical Officer Sell 46.3 -10,819 -4.12% ✗ $37.1K
Jun 20, 2024 Jun 21, 2024 MORRIS TIMOTHY E Director Neutral 52.5 - 0.00% ✗ -
Jun 20, 2024 Jun 21, 2024 Taglietti Marco Director Neutral 52.5 - 0.00% ✗ -
Jun 20, 2024 Jun 21, 2024 BROWN GREGORY B Director Neutral 52.5 - 0.00% ✗ -
Jun 20, 2024 Jun 21, 2024 Krop Julie Director Neutral 52.5 - 0.00% ✗ -
Jun 20, 2024 Jun 21, 2024 Cochran John Director Neutral 52.5 - 0.00% ✗ -
Jun 20, 2024 Jun 21, 2024 COSTA SANTO J Director Neutral 52.5 - 0.00% ✗ -
Jun 12, 2024 Korczynski Sherry SVP Sales and Marketing Neutral 52.5 - 0.00% ✗ -
Jun 7, 2024 Jun 11, 2024 Korczynski Sherry SVP Sales and Marketing Neutral 90.0 +25,000 100.00% ✗ -
Jun 11, 2024 Korczynski Sherry SVP Sales and Marketing Neutral 52.5 - 0.00% ✗ -
May 10, 2024 May 13, 2024 Wargacki Stephen Chief Science Officer Neutral 82.5 +10,000 3.88% ✗ -
May 10, 2024 May 13, 2024 Jenkins Abigail L. Director Neutral 52.5 - 0.00% ✗ -
Apr 26, 2024 Jenkins Abigail L. Director Neutral 52.5 - 0.00% ✗ -
Mar 15, 2024 Mar 19, 2024 Schobel Alexander Mark Chief Innovation/Tech Officer Sell 35.0 -50,000 -4.83% ✓ $300K
Mar 9, 2024 Mar 12, 2024 Barber Daniel CEO Sell 42.5 -37,938 -4.30% ✗ $185.1K
Mar 9, 2024 Mar 12, 2024 Boyd Peter E. Officer Sell 46.3 -8,370 -3.40% ✗ $40.8K
Mar 9, 2024 Mar 12, 2024 BRAENDER LORI J SVP, General Counsel Sell 42.5 -10,530 -3.25% ✗ $51.4K
Mar 9, 2024 Mar 12, 2024 TOTH A ERNEST JR CFO Sell 42.5 -11,705 -4.50% ✗ $57.1K
Mar 9, 2024 Mar 12, 2024 Wargacki Stephen SVP, Research & Development Sell 42.5 -12,956 -4.78% ✗ $63.2K
Mar 9, 2024 Mar 12, 2024 Jung Cassie SVP, Operations Sell 46.3 -9,432 -3.78% ✗ $46K
Mar 8, 2024 Mar 12, 2024 Schobel Alexander Mark Chief Innovation/Tech Officer Sell 41.3 -30,895 -2.90% ✓ $158.5K
Mar 7, 2024 Mar 11, 2024 BRAENDER LORI J SVP, General Counsel Neutral 90.0 +135,000 71.52% ✗ -
Mar 7, 2024 Mar 11, 2024 TOTH A ERNEST JR CFO Neutral 90.0 +120,000 85.71% ✗ -
Mar 7, 2024 Mar 11, 2024 Schobel Alexander Mark Chief Innovation/Tech Officer Neutral 85.0 +82,500 8.39% ✗ -
Mar 7, 2024 Mar 11, 2024 Kraus Carl N Chief Medical Officer Neutral 90.0 +112,500 75.00% ✗ -
Mar 7, 2024 Mar 11, 2024 Barber Daniel CEO Neutral 90.0 +242,600 37.86% ✗ -
Mar 10, 2023 Mar 11, 2024 Jung Cassie SVP, Operations Neutral 90.0 +99,885 66.88% ✗ -
Mar 7, 2024 Mar 11, 2024 Boyd Peter E. Officer Neutral 90.0 +86,250 53.99% ✗ -
Mar 10, 2023 Mar 11, 2024 Wargacki Stephen SVP, Research & Development Sell 90.0 +110,519 68.90% ✗ $1.6K
Aug 9, 2023 Aug 9, 2023 BRAENDER LORI J SVP, General Counsel Neutral 52.5 - 0.00% ✗ -
Aug 9, 2023 Aug 9, 2023 Barber Daniel CEO Neutral 52.5 - 0.00% ✗ -
Aug 9, 2023 Aug 9, 2023 Marshall Ken W. SVP, Chief Commercial Officer Neutral 52.5 - 0.00% ✗ -
Aug 9, 2023 Aug 9, 2023 Boyd Peter E. Officer Neutral 52.5 - 0.00% ✗ -
Aug 9, 2023 Aug 9, 2023 Kraus Carl N Chief Medical Officer Neutral 90.0 +150,000 100.00% ✗ -
Aug 9, 2023 Aug 9, 2023 Wargacki Stephen SVP, Research & Development Neutral 52.5 - 0.00% ✗ -
Aug 9, 2023 Aug 9, 2023 TOTH A ERNEST JR CFO Neutral 52.5 - 0.00% ✗ -
Aug 9, 2023 Aug 9, 2023 Schobel Alexander Mark Chief Innovation/Tech Officer Neutral 52.5 - 0.00% ✗ -
Aug 9, 2023 Aug 9, 2023 Jung Cassie SVP, Operations Neutral 52.5 - 0.00% ✗ -
Jun 30, 2023 Kraus Carl N CHIEF MEDICAL OFFICER Neutral 52.5 - 0.00% ✗ -
Jun 21, 2023 Jun 23, 2023 BROWN GREGORY B Director Neutral 52.5 - 0.00% ✗ -
Jun 21, 2023 Jun 23, 2023 Krop Julie Director Neutral 52.5 - 0.00% ✗ -
Jun 21, 2023 Jun 23, 2023 MORRIS TIMOTHY E Director Neutral 52.5 - 0.00% ✗ -
Jun 21, 2023 Jun 23, 2023 Taglietti Marco Director Neutral 52.5 - 0.00% ✗ -
Jun 21, 2023 Jun 23, 2023 COSTA SANTO J Director Neutral 52.5 - 0.00% ✗ -
Jun 21, 2023 Jun 23, 2023 Cochran John Director Neutral 52.5 - 0.00% ✗ -
May 5, 2023 May 5, 2023 Wargacki Stephen SVP, Research & Development Neutral 52.5 - 0.00% ✗ -
May 5, 2023 May 5, 2023 TOTH A ERNEST JR CFO Neutral 52.5 - 0.00% ✗ -
May 5, 2023 May 5, 2023 Schobel Alexander Mark Chief Innovation/Tech Officer Neutral 52.5 - 0.00% ✗ -
May 5, 2023 May 5, 2023 BRAENDER LORI J SVP, General Counsel Neutral 52.5 - 0.00% ✗ -
May 5, 2023 May 5, 2023 Barber Daniel CEO Neutral 52.5 - 0.00% ✗ -
May 5, 2023 May 5, 2023 Marshall Ken W. SVP, Chief Commercial Officer Neutral 52.5 - 0.00% ✗ -
May 5, 2023 May 5, 2023 Jung Cassie SVP, Operations Neutral 52.5 - 0.00% ✗ -
May 5, 2023 May 5, 2023 Boyd Peter E. Officer Neutral 52.5 - 0.00% ✗ -
Mar 9, 2023 Mar 9, 2023 Boyd Peter E. Officer Neutral 90.0 +100,000 167.98% ✗ -
Mar 9, 2023 Mar 9, 2023 Marshall Ken W. SVP, Chief Commercial Officer Neutral 90.0 +150,000 10380.62% ✗ -
Mar 9, 2023 Mar 9, 2023 Jung Cassie SVP, Operations Neutral 90.0 +110,000 283.57% ✗ -
Mar 9, 2023 Mar 9, 2023 Schobel Alexander Mark Chief Innovation/Tech Officer Neutral 90.0 +100,000 11.33% ✗ -
Mar 9, 2023 Mar 9, 2023 Barber Daniel CEO Neutral 90.0 +447,000 230.77% ✗ -
Mar 9, 2023 Mar 9, 2023 BRAENDER LORI J SVP, General Counsel Neutral 90.0 +150,000 386.99% ✗ -
Mar 9, 2023 Mar 9, 2023 Wargacki Stephen SVP, Research & Development Neutral 90.0 +135,000 500.82% ✗ -
Mar 9, 2023 Mar 9, 2023 TOTH A ERNEST JR CFO Neutral 90.0 +140,000 100.00% ✗ -
Jan 11, 2023 Jung Cassie SVP, Operations Neutral 52.5 - 0.00% ✗ -
Jan 11, 2023 Wargacki Stephen SVP, Research & Development Neutral 52.5 - 0.00% ✗ -